UiPath (PATH) Registers a Bigger Fall Than the Market: Important Facts to Note UiPath (PATH) closed at $13.82 in the latest trading session, marking a -1.99% move from the prior day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
NIO Inc. (NIO) Suffers a Larger Drop Than the General Market: Key Insights In the latest trading session, NIO Inc. (NIO) closed at $4.65, marking a -2.31% move from the previous day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
JD.com, Inc. (JD) Sees a More Significant Dip Than Broader Market: Some Facts to Know In the closing of the recent trading day, JD.com, Inc. (JD) stood at $32.54, denoting a -1.3% move from the preceding trading day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
Why the Market Dipped But Nu Holdings Ltd. (NU) Gained Today Nu Holdings Ltd. (NU) reached $14.48 at the closing of the latest trading day, reflecting a +1.05% change compared to its last close. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
Zoom Communications (ZM) Suffers a Larger Drop Than the General Market: Key Insights In the most recent trading session, Zoom Communications (ZM) closed at $100.64, indicating a -1.45% shift from the previous trading day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors Hims & Hers Health, Inc. (HIMS) closed at $31.65 in the latest trading session, marking a -1.59% move from the prior day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
TJX (TJX) Gains As Market Dips: What You Should Know In the latest trading session, TJX (TJX) closed at $159.92, marking a +1.5% move from the previous day. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
Nike (NKE) Increases Despite Market Slip: Here's What You Need to Know Nike (NKE) closed the most recent trading day at $42.45, moving +2.22% from the previous trading session. zacks.com zacks.com / feeds zacks-com / / #money / / 10 minutes 10m Share
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates Vanda (VNDA) delivered earnings and revenue surprises of -103.92% and -19.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? zacks.com zacks.com / feeds zacks-com / / #money / / 48 minutes 48m Share
The Cheapest ETFs for Building a Core Portfolio These lowest-cost ETFs are an excellent tool for building long-term wealth. zacks.com zacks.com / feeds zacks-com / / #money / / 1 hour 1h Share